VetClick
Menu Menu
Login

VetClick

/ News
Friday, 26th April 2024 | 4,378 veterinary jobs online | 123 people actively seeking work | 5,485 practices registered

Veterinary Industry News

Send us your news

New Dental Claim For PREVICOX®

13 years ago
4575 views

Posted
5th September, 2011 10h08


Merial are pleased to announce a unique new indication for the highly selective canine NSAID PREVICOX®. The product is now licensed for the relief of pain and inflammation associated with dental surgery in dogs. Previcox Packs x2 An estimated 70% of dogs over 2 years of age may have some degree of periodontal disease1. Extraction of teeth is often necessary for the successful management of this condition and is regarded as a painful procedure. The ability of PREVICOX® to control the pain associated with dental surgery has recently been demonstrated in a double blinded, controlled trial2 in which dogs underwent maxillary canine tooth extraction. The results showed that PREVICOX® treatment significantly reduced pain scores post dental surgery, making it the only NSAID with a specific claim for relief of post-operative dental pain. Results of physical examination and blood testing also confirmed the peri-operative safety profile of PREVICOX®, with no treatment-related adverse effects noted during the trial. The benefits of PREVICOX®To find out more contact your Merial Territory Manager on 0870 6000 123. For more information on PREVICOX visit www.previcoxfordogs.co.uk 1 Wiggs RB and Lobprise HB. Periodontology. In: Veterinary Dentistry, Principles and Practice. Philadelphia: Lippincott-Raven; 1997. p187 2 Merial Internal data PR&D0116401.

More from


You might be interested in...